GlucoTrack Inc
Research GlucoTrack Inc (GCTK) on Bullrun: market cap USD 484.07K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGCTK
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 484.07K
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 3.81M
- Free cash flow-USD 3.62M
Valuation Snapshot
latest market cap is USD 484.07K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 19.39M | -USD 15.34M | n/a | 31.22 | USD 7.38M | USD 3.45M | USD 2.83M |
| FY2024 | USD 0 | -USD 22.60M | -USD 12.59M | n/a | 4106 | USD 5.62M | USD 267.00K | -USD 13.00M |
| FY2023 | USD 0 | -USD 7.10M | -USD 6.56M | n/a | 34.18 | USD 4.49M | USD 196.00K | USD 3.20M |
| FY2022 | USD 0 | -USD 4.44M | -USD 3.73M | n/a | 0.29 | USD 2.31M | USD 195.00K | USD 1.23M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 484.07K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.52M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.91M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 5.50M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 22.00M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 65.05M | n/a | n/a | n/a |
About GlucoTrack Inc
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GlucoTrack Inc's market cap?
GlucoTrack Inc's market capitalization is USD 484.07K.
What does GlucoTrack Inc do?
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.